TCI Wealth Advisors, Inc. - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is and the CUSIP is 40434H302. A total of 11 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q1 2023$6
-25.0%
20.0%0.00%–
Q4 2022$8–2–0.00%–
 Download
Other shareholders

There were no reported owners of HTG MOLECULAR DIAGNOSTICS IN in Q4 2022.

NameSharesValueWeighting ↓
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders